The holistic integration of virtual screening in drug discovery

Drug Discovery Today

Volumn 18, Issue 7-8, 2013, Pages 358-364

  Tanrikulu, Yusuf ^a   Krüger, Björn ^a   Proschak, Ewgenij ^b  

^a MERZ PHARMACEUTICALS GMBH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG RESEARCH; NONHUMAN; PUBLICATION; REVIEW; VIRTUAL REALITY; VIRTUAL SCREENING;

DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; SMALL MOLECULE LIBRARIES;

EID: 84875150414     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.01.007     Document Type: Review

References (41)

1. C.A. Lipinski Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25 (Pubitemid 27046991)
2. D. Stumpfe Virtual compound screening in drug discovery Fut. Med. Chem. 4 2012 593 602
3. J. Bajorath Integration of virtual and high-throughput screening Nat. Rev. Drug Discov. 1 2002 882 894 (Pubitemid 37361583)
4. T. Polgár, and G. Keseru Integration of virtual and high throughput screening in lead discovery settings Comb. Chem. High Throughput Screen. 14 2011 889 897
5. P. Ripphausen State-of-the-art in ligand-based virtual screening Drug Discov. Today 16 2011 372 376
6. P. Ripphausen Quo vadis, virtual screening? A comprehensive survey of prospective applications J. Med. Chem. 53 2010 8461 8467
7. J.D. Holliday Multiple search methods for similarity-based virtual screening: analysis of search overlap and precision J. Cheminform. 3 2011 1 15
8. B. Pirard The discovery of Kv1.5 blockers as a case study for the application of virtual screening approaches J. Chem. Inf. Model. 45 2005 477 485 (Pubitemid 40635355)
9. M. Rarey, and J.S. Dixon Feature trees: a new molecular similarity measure based on tree matching J. Comput. Aided Mol. Des. 12 1998 471 490 (Pubitemid 128512818)
10. M. Rarey, and M. Stahl Similarity searching in large combinatorial chemistry spaces J. Comput. Aided Mol. Des. 15 2001 497 520 (Pubitemid 32680852)
11. T. Tömöri Combining 2D and 3D in silico methods for rapid selection of potential PDE5 inhibitors from multimillion compounds' repositories: biological evaluation Mol. Divers. 16 2012 59 72
12. D.J. Rogers, and T.T. Tanimoto A computer program for classifying plants Science 132 1960 1115 1118
13. G. Jones Development and validation of a genetic algorithm for flexible docking J. Mol. Biol. 267 1997 727 748 (Pubitemid 27170693)
14. G. Xia Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening Bioorg. Med. Chem. Lett. 21 2011 5739 5744
15. J.A. Grant A fast method of molecular shape comparison: a simple application of a Gaussian description of molecular shape J. Comput. Chem. 17 1996 1653 1666 (Pubitemid 126535414)
16. R.A. Friesner Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy J. Med. Chem. 47 2004 1739 1749 (Pubitemid 38380917)
17. F. Svensson Virtual screening data fusion using both structure- and ligand-based methods J. Chem. Inf. Model. 52 2011 225 232
18. N. Huang Benchmarking sets for molecular docking J. Med. Chem. 49 2006 6789 6801 (Pubitemid 44749746)
19. L. Weber Optimization of the biological activity of combinatorial compound libraries by a genetic algorithm Angew. Chem. Int. 34 1995 2280 2282
20. J. Zander Multistep virtual screening for rapid and efficient identification of non-nucleoside bacterial thymidine kinase inhibitors Chem. Eur. J. 16 2010 9630 9637
21. G. Schneider 'Scaffold-hopping' by topological pharmacophore search: a contribution to virtual screening Angew. Chem. Int. 38 1999 2894 2896 (Pubitemid 29479958)
22. T. Kohonen Self-organized formation of topologically correct feature maps Biol. Cybern. 43 1982 59 69 (Pubitemid 12139984)
23. V. Hähnke PhAST: pharmacophore alignment search tool J. Comput. Chem. 30 2009 761 771
24. Y. Tanrikulu Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor ChemMedChem 4 2009 820 827
25. M.J. Vainio ShaEP: molecular overlay based on shape and electrostatic potential J. Chem. Inf. Model. 49 2009 492 502
26. B. Hofmann Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenase ChemMedChem 3 2008 1535 1538
27. B. Hofmann A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors J. Med. Chem. 54 2011 1943 1947
28. M. Hieke SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase Bioorg. Med. Chem. Lett. 22 2012 1969 1975
29. C. de Graaf Crystal structure-based virtual screening for fragment-like ligands of the human histamine H1 receptor J. Med. Chem. 54 2011 8195 8206
30. R. Mueller Identification of metabotropic glutamate receptor subtype 5 potentiators using virtual high-throughput screening ACS Chem. Neurosci. 1 2010 288 305
31. N. Brown A chemoinformatics analysis of hit lists obtained from high-throughput affinity-selection screening J. Biomol. Screen. 11 2006 123 130
32. G.W. Bemis, and M.A. Murcko The properties of known drugs. 1. Molecular frameworks J. Med. Chem. 39 1996 2887 2893 (Pubitemid 26251026)
33. C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 44 2000 235 249 (Pubitemid 32239479)
34. J.L. Jenkins Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin Proteins 50 2003 81 93 (Pubitemid 36090610)
35. S. Betzi Protein-protein interaction inhibition (2P2I) combining high throughput and virtual screening: application to the HIV-1 Nef protein Proc. Natl. Acad. Sci. U. S. A. 104 2007 19256 19261
36. T. Polgár Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3β inhibitors J. Med. Chem. 48 2005 7946 7959 (Pubitemid 41798426)
37. J.B. Kruskal Multidimensional scaling by optimizing goodness of fit to a nonmetric hypothesis Psychometrika 29 1964 1 27
38. G. Klebe Virtual ligand screening: strategies, perspectives and limitations Drug Discov. Today 11 2006 580 594
39. H. Eckert, and J. Bajorath Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches Drug Discov. Today 12 2007 225 233
40. J. Bajorath Progress in computational medicinal chemistry J. Med. Chem. 55 2012 3593 3594
41. I. Khanna Drug discovery in pharmaceutical industry: productivity challenges and trends Drug Discov. Today 17 2012 1088 1102